FR1830M - New drug in particular for the treatment of follicle-stimulating hyperactivity. - Google Patents

New drug in particular for the treatment of follicle-stimulating hyperactivity.

Info

Publication number
FR1830M
FR1830M FR876602A FR876602A FR1830M FR 1830 M FR1830 M FR 1830M FR 876602 A FR876602 A FR 876602A FR 876602 A FR876602 A FR 876602A FR 1830 M FR1830 M FR 1830M
Authority
FR
France
Prior art keywords
hyperactivity
follicle
stimulating
treatment
new drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR876602A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR876602A priority Critical patent/FR1830M/en
Application granted granted Critical
Publication of FR1830M publication Critical patent/FR1830M/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
FR876602A 1961-10-20 1961-10-20 New drug in particular for the treatment of follicle-stimulating hyperactivity. Active FR1830M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR876602A FR1830M (en) 1961-10-20 1961-10-20 New drug in particular for the treatment of follicle-stimulating hyperactivity.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR876602A FR1830M (en) 1961-10-20 1961-10-20 New drug in particular for the treatment of follicle-stimulating hyperactivity.

Publications (1)

Publication Number Publication Date
FR1830M true FR1830M (en) 1963-05-27

Family

ID=87572565

Family Applications (1)

Application Number Title Priority Date Filing Date
FR876602A Active FR1830M (en) 1961-10-20 1961-10-20 New drug in particular for the treatment of follicle-stimulating hyperactivity.

Country Status (1)

Country Link
FR (1) FR1830M (en)

Similar Documents

Publication Publication Date Title
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR1830M (en) New drug in particular for the treatment of follicle-stimulating hyperactivity.
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
FR1204M (en) New drug, in particular for the treatment of chronic or post-prandial hyperlipemia.
FR2323M (en) New drug, in particular for the treatment of follicle-stimulating hyperactivity.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1122M (en) New drug in particular for the treatment of hypercholesterolemia.
FR3096M (en) New drug in particular for the treatment of states of adynamia.
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR3419M (en) New drugs, in particular for the treatment of neuro-depressive states and anxiety psychoses.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR1512M (en) New drug in particular for the treatment of arterial hypertension.
FR1466M (en) New drug in particular for the treatment of arterial hypertension.
FR2458M (en) New drug in particular for the treatment of depressive states or anxiety.
FR1780M (en) New drug in particular for the treatment of disorders of protein anabolism.
FR1729M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR1039M (en) Ribonuclease-based medicine for the treatment of psoriasis and other dermatoses.
FR1288M (en) New drug, in particular for the treatment of postprandial or acute hyperlipemia.
FR1547M (en) New drug, in particular for the treatment of hypophyseal follicle stimulating hyperactivity.
FR3126M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR3315M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR3268M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR3062M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR2885M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.